Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grant R Zimmermann

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|March 26, 2009
NMR chemical exchange as a probe for ligand-binding kinetics in a theophylline-binding RNA aptamerMichael P Latham, Grant R Zimmermann, Arthur Pardi
Drug Discovery Today|January 3, 2007
Multi-target therapeutics: when the whole is greater than the sum of the partsGrant R Zimmermann, Joseph Lehár, Curtis T Keith
Discovery Medicine|December 31, 2009
Therapeutic selectivity and the multi-node drug targetJoseph Lehar, Andrew S Krueger, Grant R Zimmermann, et al.
Arthritis Research & Therapy|January 28, 2009
Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drugGrant R Zimmermann, William Avery, Alyce L Finelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2003
Systematic discovery of multicomponent therapeuticsAlexis A Borisy, Peter J Elliott, Nicole W Hurst, et al.
Nature Biotechnology|July 8, 2009
Synergistic drug combinations tend to improve therapeutically relevant selectivityJoseph Lehár, Andrew S Krueger, William Avery, et al.
Molecular Systems Biology|March 3, 2007
Chemical combination effects predict connectivity in biological systemsJoseph Lehár, Grant R Zimmermann, Andrew S Krueger, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|March 26, 2009
NMR chemical exchange as a probe for ligand-binding kinetics in a theophylline-binding RNA aptamerMichael P Latham, Grant R Zimmermann, Arthur Pardi
Drug Discovery Today|January 3, 2007
Multi-target therapeutics: when the whole is greater than the sum of the partsGrant R Zimmermann, Joseph Lehár, Curtis T Keith
Discovery Medicine|December 31, 2009
Therapeutic selectivity and the multi-node drug targetJoseph Lehar, Andrew S Krueger, Grant R Zimmermann, et al.
Arthritis Research & Therapy|January 28, 2009
Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drugGrant R Zimmermann, William Avery, Alyce L Finelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2003
Systematic discovery of multicomponent therapeuticsAlexis A Borisy, Peter J Elliott, Nicole W Hurst, et al.
Nature Biotechnology|July 8, 2009
Synergistic drug combinations tend to improve therapeutically relevant selectivityJoseph Lehár, Andrew S Krueger, William Avery, et al.
Molecular Systems Biology|March 3, 2007
Chemical combination effects predict connectivity in biological systemsJoseph Lehár, Grant R Zimmermann, Andrew S Krueger, et al.
Pageof 1